Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This year marks the 200th anniversary of the publication of the first codified description of the condition that we now know as Parkinson's disease.

Associate Professor Chrystalina Antoniades from the Nuffield Department of Clinical Neurosicences, and Dr Patrick Lewis from the University of Reading have co-organised the following events to mark the anniversary, together with the Oxford branch of Parkinson's UK.

Exhibition, 11-19 September

The author of the publication describing the condition, James Parkinson, called the disease the Shaking Palsy. Parkinson's talents, however, stretched well beyond neurology. He was a political agitator, general science writer and an influential geologist - all aspects of his work that are showcased in an exhibition from the collections of the Bodleian Library.

Conference, 18 September

This conference for people with Parkinson's, families, friends and healthcare professionals is devised and presented by Parkinson's UK Oxford Branch in collaboration with the University of Oxford's Nuffield Department of Clinical Neurosciences and other leading organisations.

Sessions cover:

  • Progress in research and therapy
  • Sharing best practice
  • Achieving best quality of life

Read more about the conference.

Similar stories

Attention and memory deficits persist for months after recovery from mild COVID

Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.

New spinout company: Human-Centric Drug Discovery

Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.

Funding received for research into Motor Neuron Disease

A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.

Protein test could lead to earlier and better diagnosis of Parkinson’s

Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.

Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.